Concord Drugs

Concord Drugs

56.00
0.00
(0.00%)
Market Cap
56.00 Cr
EPS
0.34
PE Ratio
164.71
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
67.00
52 Week Low
26.10
PB Ratio
1.64
Debt to Equity
0.53
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,733.80
#1 4,15,996.70
35.83
#1 54,729.00
12.06
#1 10,980
-18.99
64.93
6,650.00
1,76,536.61
80.94
9,712.00
0.89
2,191
23.05
46.65
3,730.60
1,26,260.46
63.15
11,539.40
6.99
1,911
19.91
74.11
1,559.40
1,25,953.96
23.58
28,409.50
7.12
5,291
9.88
65.36
1,292.10
1,07,834.93
#1 19.10
33,741.20
16.73
5,725
1.26
55.19
2,575.50
1,06,298.29
60.68
12,744.20
19.57
2,007
-10.91
55.92
995.15
1,00,135.38
21.54
23,511.00
13.82
4,615
-0.19
61.25
1,984.60
90,635.78
27.91
22,909.50
#1 19.94
3,306
#1 112.49
58.19
35,195.00
74,786.92
52.17
6,684.70
10.80
1,414
27.83
60.78
1,158.00
67,256.83
19.47
31,378.10
17.55
3,366
-0.50
55.87
Forecast
Actual
Growth Rate
Revenue Growth
-13.82 %
Net Income Growth
-50.00 %
Cash Flow Change
-52.41 %
ROE
-54.98 %
ROCE
-17.47 %
EBITDA Margin (Avg.)
2.62 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
16
13
14
14
12
9
8
13
16
12
12
11
10
Expenses
15
12
13
12
11
8
6
12
15
11
12
9
9
EBITDA
1
1
1
1
1
2
2
1
0
1
1
1
1
Operating Profit %
4 %
8 %
9 %
11 %
8 %
16 %
21 %
5 %
2 %
7 %
7 %
13 %
10 %
Depreciation
0
0
1
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
1
0
0
1
1
0
1
1
1
Profit Before Tax
0
0
0
1
0
1
1
-0
-1
0
0
1
0
Tax
0
0
0
0
0
0
0
0
-0
0
0
0
0
Net Profit
0
0
0
0
0
1
1
-0
-0
0
0
0
0
EPS in ₹
0.03
0.21
0.21
0.52
0.17
0.53
0.60
-0.24
-0.34
0.03
0.04
0.23
0.04

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
56
58
59
65
Fixed Assets
14
13
12
14
Current Assets
42
44
45
41
Capital Work in Progress
1
1
2
2
Investments
0
1
1
25
Other Assets
42
44
45
0
Total Liabilities
56
58
59
65
Current Liabilities
24
22
21
26
Non Current Liabilities
4
5
4
5
Total Equity
28
32
34
34
Reserve & Surplus
20
22
24
24
Share Capital
9
9
10
10

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
0
0
0
Investing Activities
-2
-2
-1
Operating Activities
1
2
1
Financing Activities
2
1
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
44.38 %
49.00 %
49.00 %
49.00 %
49.00 %
49.00 %
49.00 %
49.00 %
52.13 %
52.13 %
52.13 %
55.41 %
55.41 %
55.41 %
55.41 %
54.39 %
54.39 %
54.39 %
54.39 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
54.90 %
50.05 %
50.05 %
50.47 %
50.65 %
50.68 %
50.67 %
50.71 %
47.60 %
47.59 %
47.54 %
44.29 %
44.27 %
44.28 %
44.30 %
45.11 %
45.11 %
43.33 %
42.57 %
Others
0.73 %
0.95 %
0.95 %
0.53 %
0.35 %
0.32 %
0.33 %
0.29 %
0.27 %
0.28 %
0.33 %
0.30 %
0.32 %
0.31 %
0.29 %
0.50 %
0.50 %
2.28 %
3.04 %
No of Share Holders
2,173
2,826
2,826
3,071
3,047
3,036
3,188
3,321
3,215
3,198
3,957
3,963
4,032
4,734
4,755
5,073
5,073
5,252
5,189

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
31 Jul 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
31 Jul 2025 55.48 56.00
30 Jul 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
30 Jul 2025 51.45 56.00
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 31.98 31.97
11 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Jan 2025 37.38 36.71
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 38.11 36.87
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 37.89 37.27

Announcements

Corrigendum To The Notice Of EGM8 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Notice Of EGMJul 09, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationJul 03, 2025
Board Meeting Outcome for Out Come Of Board MeetingJul 03, 2025
Clarification Letter Sought From BSEJul 02, 2025
Clarification sought from Concord Drugs LtdJul 02, 2025
Board Meeting Intimation for Issue Of Shares Through Preferential AllotmentJun 30, 2025
Board Meeting Outcome for Outcome Of Board MeetingJun 27, 2025
Closure of Trading WindowJun 26, 2025
Board Meeting Intimation for Considering And Approval Of Preferential IssueJun 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Financial Results For Quarter And Financial Year Ending March 31 St 2025.May 23, 2025
Board Meeting Outcome for Board Meeting Outcome For Audited Results To Consider Audited Results For Year Ending March 31St 2025May 23, 2025
Board Meeting Intimation for Consideration And Approval Of Audited ResultsMay 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Closure of Trading WindowMar 26, 2025
Board Meeting Outcome for Outcome Of Board MeetingMar 17, 2025
Board Meeting Intimation for Reschedule Of Board MeetingMar 13, 2025
Board Meeting Intimation for To Consider Fund Raising By Way Of Preferential IssueMar 04, 2025
Integrated Filing (Financial)Jan 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 17, 2025
Board Meeting Outcome for Outcome Of Board MeetingJan 11, 2025
Financial Results For 31St December2024Jan 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Board Meeting Intimation for Consider And Approval Of Un-Audited Financial ResultsJan 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Financial Results For Q2 Ending Sep 30, 2024Nov 13, 2024
Board Meeting Outcome for Financial Results For Quarter Ended 30 September 2024Nov 13, 2024
Board Meeting Intimation for Quarterly Results For 30 September, 2024Nov 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 21, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 01, 2024
Closure of Trading WindowSep 30, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2024
Revised Outcome Of Board Meeting.Sep 30, 2024
Financial Results For Q1 JUNE 2024Sep 12, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2024
Reg. 34 (1) Annual Report.Sep 06, 2024
Book Closure.Sep 06, 2024
Annual General Meeting To Be Held On 30.09.2024Sep 06, 2024
Board Meeting Outcome for Outcome Of Board MeetingSep 06, 2024
Board Meeting Intimation for Meeting To Be Held On 06.09.2024.Sep 02, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2024
Re-Submission Of Financial Results For Year/Quarter Ended 31.03.2024Aug 09, 2024
Board Meeting Outcome for Outcome Of Board MeetingAug 09, 2024
Declaration Of Financial Results For Quarter Ended 30.06.2024Aug 09, 2024
Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited(Standalone & Consolidated) Financial Results For 1St Quarter, 2024 .Aug 03, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 16, 2024
Closure of Trading WindowJun 30, 2024

Technical Indicators

RSI(14)
Neutral
58.14
ATR(14)
Less Volatile
2.21
STOCH(9,6)
Oversold
13.44
STOCH RSI(14)
Oversold
1.54
MACD(12,26)
Bearish
-1.52
ADX(14)
Strong Trend
42.26
UO(9)
Bearish
41.81
ROC(12)
Downtrend And Accelerating
-15.04
WillR(14)
Oversold
-90.76